Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 178, Issue 5, Pages 689-698Publisher
WILEY
DOI: 10.1111/bjh.14713
Keywords
myeloproliferative neoplasm; familial; JAK2; CALR; MPL
Categories
Funding
- Associazione Italiana per la Ricerca sul Cancro (AIRC
- Milan, Italy)
- Special Program Molecular Clinical Oncology [1005]
- AIRC [MFAG-2014-15672]
Ask authors/readers for more resources
Myeloproliferative neoplasms (MPNs) are generally acquired as a result of a somatic stem cell mutation leading to clonal expansion of myeloid precursors. In addition to sporadic cases, familial MPN occurs when one or several MPN affect different relatives of the same family. MPN driver mutations (JAK2, CALR, MPL) are somatically acquired also in familial cases, so a genetic predisposition to acquire one of the MPN driver mutations would be inherited, even though the causative germline mutations underlying familial MPN remain largely unknown. Recently some germline variants [ATG2B and GSKIP duplication, RBBP6 mutations, SH2B3 (LNK) mutations], which can cause familial MPN, have been reported but these mutations are rare and do not explain most familial cases. Patients with familial MPN show the same clinical features and suffer the same complications as those with sporadic disease. This review aims to offer up-to-date information regarding the genetics of familial MPN.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available